Bill Text: NY S01619 | 2025-2026 | General Assembly | Introduced

---

Bill Title: Allows a licensed pharmacist to order and administer certain tests.

Spectrum: Slight Partisan Bill (Democrat 10-5)

Status: (Introduced) 2025-01-27 - ADVANCED TO THIRD READING [S01619 Detail]

Download: New_York-2025-S01619-Introduced.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                          1619

                               2025-2026 Regular Sessions

                    IN SENATE

                                    January 13, 2025
                                       ___________

        Introduced  by  Sens.  RIVERA,  ADDABBO,  BORRELLO, GALLIVAN, GOUNARDES,
          HELMING, KRUEGER, MAY, MURRAY, SALAZAR, SEPULVEDA, SKOUFIS, WEBB, WEIK
          -- read twice and ordered printed, and when printed to be committed to
          the Committee on Health

        AN ACT to amend the education law, in relation to  allowing  a  licensed
          pharmacist  to order and administer certain tests; and to amend part C
          of chapter 57 of the laws of 2022 amending the public health  law  and
          the  education  law relating to allowing pharmacists to direct limited
          service laboratories and order and administer COVID-19  and  influenza
          tests  and  modernizing nurse practitioners, in relation to the effec-
          tiveness thereof

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:

     1    Section  1.  Subdivision  7  of  section 6801 of the education law, as
     2  added by section 2 of part C of chapter 57  of  the  laws  of  2022,  is
     3  amended to read as follows:
     4    7. A licensed pharmacist is a qualified health care professional under
     5  section  five  hundred  seventy-one  of  the  public  health law for the
     6  purposes of directing a limited  service  laboratory  and  ordering  and
     7  administering  COVID-19  [and],  influenza,  respiratory syncytial virus
     8  (RSV), pharyngitis resulting from a  Group  A  streptococcal  infection,
     9  HbA1c, hepatitis C, and human immunodeficiency virus (HIV) tests author-
    10  ized  by  the Food and Drug Administration (FDA), subject to certificate
    11  of waiver requirements established  pursuant  to  the  federal  clinical
    12  laboratory improvement act of nineteen hundred eighty-eight.
    13    §  2.  Section  8 of part C of chapter 57 of the laws of 2022 amending
    14  the public health law and the education law relating to allowing pharma-
    15  cists to direct limited service laboratories and  order  and  administer
    16  COVID-19  and  influenza  tests  and modernizing nurse practitioners, as
    17  amended by section 1 of part P of chapter 57 of the  laws  of  2024,  is
    18  amended to read as follows:

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD04152-01-5
        S. 1619                             2

     1    §  8.  This  act  shall take effect immediately and shall be deemed to
     2  have been in full force and effect on and after April 1, 2022; provided,
     3  however, that sections one, two, three, four, six and seven of this  act
     4  shall expire and be deemed repealed July 1, [2026] 2028.
     5    §  3.  This act shall take effect immediately; provided, however, that
     6  the amendments to subdivision 7 of section 6801  of  the  education  law
     7  made  by  section  one  of  this act shall not affect the repeal of such
     8  subdivision and shall be deemed repealed therewith.